Initiated with a Outperform at Cowen, Alphatec Holdings (ATEC -1.9%) has recorded an impressive 15.6% in the past one month as against a 5.9% gain in the broader index (NYSEARCA:XLK); PT of $12, indicating upside of 110.9% from current levels.
Analyst Joshua Jennings notes that the company’s turnaround story is de-risked but still in the early innings.
He further adds that the company has made major progress in revamping its product portfolio (new product revenue contribution stood at 61% vs. nil in 2Q17), distribution network, and surgeon customer base (revenue from top surgeons +51% in Q2).
Percentage of sales driven by strategic channel stands at 91% vs. 56% in 2Q17.
Upcoming share catalysts and revenue drivers include the launch of the company’s proprietary prone transpsoas technique, which should strengthen investor sentiment, says Jennings.
Read more: Earnings Call Presentation
https://seekingalpha.com/news/3611852-alphatec-initiated-outperform-on-companys-turnaround-story
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.